Identification of lncRNA HCCAT5 as a Novel Biomarker for Gastric Cancer
Conclusions: The lncRNA HCCAT5 is implicated in advancing the development of GC. Consequently, it could be considered a potential target for therapeutic interventions and a prognostic biomarker for GC patients.
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | International Journal of Genomics |
| Online Access: | http://dx.doi.org/10.1155/ijog/9917434 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|